Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China
· Delayed Price · Currency is CNY 10.10
+0.28 (2.85%)
Apr 30, 2026, 3:04 PM CST
SHE:002873 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 2,311 | 2,334 | 2,190 | 2,868 | 3,339 | 3,224 | Upgrade
|
| Market Cap Growth | 2.15% | 6.57% | -23.62% | -14.13% | 3.58% | 72.48% | Upgrade
|
| Enterprise Value | 2,806 | 2,767 | 2,805 | 3,335 | 3,673 | 3,456 | Upgrade
|
| Last Close Price | 9.82 | 9.92 | 9.37 | 12.22 | 14.11 | 13.96 | Upgrade
|
| PE Ratio | 253.75 | 256.18 | 41.86 | 35.46 | 29.94 | 32.04 | Upgrade
|
| PS Ratio | 3.08 | 3.11 | 2.55 | 3.01 | 3.07 | 3.32 | Upgrade
|
| PB Ratio | 1.84 | 1.86 | 1.83 | 2.58 | 2.98 | 3.62 | Upgrade
|
| P/TBV Ratio | 2.02 | 2.05 | 2.02 | 2.79 | 3.22 | 4.01 | Upgrade
|
| P/FCF Ratio | 71.89 | 72.62 | 82.10 | - | - | 173.24 | Upgrade
|
| P/OCF Ratio | 27.59 | 27.88 | 24.85 | 36.87 | 44.04 | 25.94 | Upgrade
|
| EV/Sales Ratio | 3.74 | 3.69 | 3.27 | 3.50 | 3.38 | 3.56 | Upgrade
|
| EV/EBITDA Ratio | 46.34 | 49.63 | 31.02 | 28.38 | 23.64 | 23.30 | Upgrade
|
| EV/EBIT Ratio | 122.72 | 121.01 | 48.26 | 34.32 | 28.09 | 27.30 | Upgrade
|
| EV/FCF Ratio | 87.29 | 86.08 | 105.13 | - | - | 185.73 | Upgrade
|
| Debt / Equity Ratio | 0.53 | 0.53 | 0.47 | 0.54 | 0.43 | 0.48 | Upgrade
|
| Debt / EBITDA Ratio | 11.05 | 11.05 | 5.87 | 5.00 | 3.11 | 2.88 | Upgrade
|
| Debt / FCF Ratio | 20.81 | 20.81 | 21.00 | - | - | 23.10 | Upgrade
|
| Net Debt / Equity Ratio | 0.39 | 0.39 | 0.37 | 0.42 | 0.34 | 0.31 | Upgrade
|
| Net Debt / EBITDA Ratio | 8.88 | 8.88 | 4.89 | 3.95 | 2.48 | 1.87 | Upgrade
|
| Net Debt / FCF Ratio | 15.40 | 15.40 | 16.57 | -19.39 | -7.22 | 14.90 | Upgrade
|
| Asset Turnover | 0.37 | 0.37 | 0.44 | 0.51 | 0.65 | 0.63 | Upgrade
|
| Inventory Turnover | 1.36 | 1.36 | 1.40 | 1.19 | 1.64 | 1.96 | Upgrade
|
| Quick Ratio | 1.25 | 1.25 | 0.97 | 0.79 | 0.81 | 1.03 | Upgrade
|
| Current Ratio | 1.71 | 1.71 | 1.28 | 1.15 | 1.22 | 1.33 | Upgrade
|
| Return on Equity (ROE) | 0.74% | 0.74% | 4.53% | 7.24% | 11.08% | 11.71% | Upgrade
|
| Return on Assets (ROA) | 0.70% | 0.70% | 1.88% | 3.24% | 4.86% | 5.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.24% | 1.26% | 3.11% | 5.51% | 8.98% | 10.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.30% | 1.30% | 4.00% | 7.20% | 9.80% | 11.70% | Upgrade
|
| Earnings Yield | 0.39% | 0.39% | 2.39% | 2.82% | 3.34% | 3.12% | Upgrade
|
| FCF Yield | 1.39% | 1.38% | 1.22% | -0.83% | -1.60% | 0.58% | Upgrade
|
| Dividend Yield | 0.31% | 0.30% | 1.07% | 0.57% | 0.71% | 0.61% | Upgrade
|
| Payout Ratio | 454.63% | 454.63% | 67.01% | 52.59% | 30.81% | 30.15% | Upgrade
|
| Buyback Yield / Dilution | -6.87% | -6.87% | 9.91% | -0.41% | 0.41% | -1.34% | Upgrade
|
| Total Shareholder Return | -6.56% | -6.57% | 10.98% | 0.16% | 1.12% | -0.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.